| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: A randomized controlled trial
|
Bilek, Furkan
|
|
|
61 |
C |
p.
|
artikel
|
| 2 |
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial
|
Bove, Riley
|
|
|
61 |
C |
p.
|
artikel
|
| 3 |
Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients
|
Abbatemarco, Justin R.
|
|
|
61 |
C |
p.
|
artikel
|
| 4 |
Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis
|
Molenaar, P.C.G.
|
|
|
61 |
C |
p.
|
artikel
|
| 5 |
Decision making process in multiple sclerosis: An Argentine pilot study
|
Alonso, Ricardo Nicolás
|
|
|
61 |
C |
p.
|
artikel
|
| 6 |
Disentangling self-reported fatigue, depression, and cognitive impairment in people with multiple sclerosis
|
Plow, Matthew
|
|
|
61 |
C |
p.
|
artikel
|
| 7 |
Efficacy and safety of rehabilitation exercise in neuromyelitis optica spectrum disorder during the acute phase: A prospective cohort study
|
Li, Qinying
|
|
|
61 |
C |
p.
|
artikel
|
| 8 |
Exploring steroid tapering in patients with neuromyelitis optica spectrum disorder treated with satralizumab in SAkuraSky: A case series
|
Yamamura, Takashi
|
|
|
61 |
C |
p.
|
artikel
|
| 9 |
Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study
|
Rauma, Ilkka
|
|
|
61 |
C |
p.
|
artikel
|
| 10 |
Health related quality of life and perceived social support in French and Lebanese MS patients: A comparative study
|
Ibrahim, M.
|
|
|
61 |
C |
p.
|
artikel
|
| 11 |
High efficacy treatment is not enough in MS: Socioeconomic factors are key to improving outcomes
|
Yeh, E. Ann
|
|
|
61 |
C |
p.
|
artikel
|
| 12 |
Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies
|
Maglione, Alessandro
|
|
|
61 |
C |
p.
|
artikel
|
| 13 |
Impact of disease-modifying therapies on MRI outcomes in patients with relapsing -remitting multiple sclerosis: A systematic review and network meta-analysis
|
Bose, Debdipta
|
|
|
61 |
C |
p.
|
artikel
|
| 14 |
Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial
|
Berard, Jason A.
|
|
|
61 |
C |
p.
|
artikel
|
| 15 |
MS or not MS: T2-weighted imaging (T2WI)-based radiomic findings distinguish MS from its mimics
|
He, Ting
|
|
|
61 |
C |
p.
|
artikel
|
| 16 |
Neuromyelitis optica spectrum disorder in Western Mexico
|
Mireles-Ramírez, Mario A.
|
|
|
61 |
C |
p.
|
artikel
|
| 17 |
Personality and its association with self-management in multiple sclerosis
|
Dietmaier, Johanna-Maria
|
|
|
61 |
C |
p.
|
artikel
|
| 18 |
Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years
|
Ghadiri, Fereshteh
|
|
|
61 |
C |
p.
|
artikel
|
| 19 |
Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse population
|
Carlson, Aaron M.
|
|
|
61 |
C |
p.
|
artikel
|
| 20 |
Prevention or reduction of alemtuzumab-induced secondary autoimmune diseases through high-dose daily vitamin D supplementation?
|
Goischke, Hans-Klaus
|
|
|
61 |
C |
p.
|
artikel
|
| 21 |
Progressive retinal changes in pediatric multiple sclerosis
|
Longoni, Giulia
|
|
|
61 |
C |
p.
|
artikel
|
| 22 |
Promising role of temelimab in multiple sclerosis treatment
|
Irfan, Shayan Ali
|
|
|
61 |
C |
p.
|
artikel
|
| 23 |
Real-life evidence of treatment with alemtuzumab in patients diagnosed with relapsing-remitting multiple sclerosis in Colombia
|
Bónitto, Juan Raúl García
|
|
|
61 |
C |
p.
|
artikel
|
| 24 |
Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis – A phase I extension study (SIAMMS II)
|
Rice, Claire M.
|
|
|
61 |
C |
p.
|
artikel
|
| 25 |
Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity
|
Kavosh, Aryan
|
|
|
61 |
C |
p.
|
artikel
|
| 26 |
Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence study
|
Henríquez, Katherine
|
|
|
61 |
C |
p.
|
artikel
|
| 27 |
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
|
Zaratin, Paola
|
|
|
61 |
C |
p.
|
artikel
|
| 28 |
The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type
|
Jakubecz, Collin
|
|
|
61 |
C |
p.
|
artikel
|
| 29 |
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort
|
Flemmen, Heidi Øyen
|
|
|
61 |
C |
p.
|
artikel
|
| 30 |
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis
|
Altieri, Manuela
|
|
|
61 |
C |
p.
|
artikel
|
| 31 |
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios
|
Carnero Contentti, Edgar
|
|
|
61 |
C |
p.
|
artikel
|
Tijdschrift beschrijving